Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure
Department of Medicine, Division of Rheumatology
Contracture; Contrast Media; Diagnosis, Differential; Gadolinium; Humans; Hyperpigmentation; Nephrogenic Fibrosing Dermopathy; induced; Renal Insufficiency, Chronic; Risk Factors; Skin
Musculoskeletal Diseases | Rheumatology | Skin and Connective Tissue Diseases
Nephrogenic systemic fibrosis (NSF) is an iatrogenic fibrosing disorder that primarily affects individuals with chronic kidney disease (CKD) following exposure to gadolinium-based contrast agents (GBCAs) during imaging procedures. NSF is characterised by skin thickening, tethering and hyperpigmentation; flexion contractures of joints; and extracutaneous fibrosis. This article reviews the history, clinical manifestations, epidemiology, histopathology and pathophysiology of this disabling disease.
Rights and Permissions
Citation: Best Pract Res Clin Rheumatol. 2012 Aug;26(4):489-503. doi: 10.1016/j.berh.2012.07.008. Link to article on publisher's site
Best practice and research. Clinical rheumatology
Bernstein, Elana J.; Schmidt-Lauber, Christian; and Kay, Jonathan, "Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure" (2012). Rheumatology Publications and Presentations. 137.